Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative Atorvastatin Regimens in CABG
NCT02706860Phase 4Completed
- Sponsor
- Cairo University
- Start
- Jun 2013
- Primary completion
- Feb 2015
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of atorvastatin in ischemic heart disease (IHD) (3 arms), sponsored by Cairo University. Primary endpoint: Major Adverse Cardiac and Cerebrovascular Events at 30 days. Started Jun 2013; status: completed.
02
Drugs
atorvastatin
03
Conditions
ischemic heart disease (IHD)
Beyond the preview
Go deeper on NCT02706860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02706860.